BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 17592284)

  • 1. The effect of antireflux surgery on esophageal carcinogenesis in patients with barrett esophagus: a systematic review.
    Chang EY; Morris CD; Seltman AK; O'Rourke RW; Chan BK; Hunter JG; Jobe BA
    Ann Surg; 2007 Jul; 246(1):11-21. PubMed ID: 17592284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antireflux surgery, barrett esophagus, and adenocarcinoma: there is still room for doubt.
    Jamieson GG
    Ann Surg; 2007 Jul; 246(1):22-3. PubMed ID: 17592285
    [No Abstract]   [Full Text] [Related]  

  • 3. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis.
    Corey KE; Schmitz SM; Shaheen NJ
    Am J Gastroenterol; 2003 Nov; 98(11):2390-4. PubMed ID: 14638338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barrett esophagus: risk factors for progression to dysplasia and adenocarcinoma.
    Oberg S; Wenner J; Johansson J; Walther B; Willén R
    Ann Surg; 2005 Jul; 242(1):49-54. PubMed ID: 15973101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversies in Barrett esophagus.
    Dunbar KB; Spechler SJ
    Mayo Clin Proc; 2014 Jul; 89(7):973-84. PubMed ID: 24867396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment modality and risk of development of dysplasia and adenocarcinoma in columnar-lined esophagus.
    Gatenby PA; Ramus JR; Caygill CP; Charlett A; Winslet MC; Watson A
    Dis Esophagus; 2009; 22(2):133-42. PubMed ID: 19018855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical treatment of Barrett's esophagus: 1980-2003.
    Csendes A
    World J Surg; 2004 Mar; 28(3):225-31. PubMed ID: 14961203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin use and the risk of esophageal cancer in Barrett esophagus.
    Agrawal S; Patel P; Agrawal A; Makhijani N; Markert R; Deidrich W
    South Med J; 2014 Dec; 107(12):774-9. PubMed ID: 25502158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus.
    Sharma P; Falk GW; Weston AP; Reker D; Johnston M; Sampliner RE
    Clin Gastroenterol Hepatol; 2006 May; 4(5):566-72. PubMed ID: 16630761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common questions about Barrett esophagus.
    Zimmerman TG
    Am Fam Physician; 2014 Jan; 89(2):92-8. PubMed ID: 24444576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus.
    Kastelein F; Spaander MC; Biermann K; Steyerberg EW; Kuipers EJ; Bruno MJ;
    Gastroenterology; 2011 Dec; 141(6):2000-8; quiz e13-4. PubMed ID: 21878200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
    Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R
    Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale for surgical therapy of Barrett esophagus.
    Bammer T; Hinder RA; Klaus A; Trastek VF; Achem SR
    Mayo Clin Proc; 2001 Mar; 76(3):335-42. PubMed ID: 11243284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
    Whitson MJ; Falk GW
    Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of Barrett's esophagus to adenocarcinoma despite antireflux surgery.
    von Conrady D; Smith MJ; Khan MF; Tan S; Mortimer G; McAnena OJ
    Endoscopy; 2008 Sep; 40 Suppl 2():E68-9. PubMed ID: 18633915
    [No Abstract]   [Full Text] [Related]  

  • 17. Antireflux surgery for dysplastic Barrett.
    Allaix ME; Patti MG
    World J Surg; 2015 Mar; 39(3):588-94. PubMed ID: 24806626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis.
    Rastogi A; Puli S; El-Serag HB; Bansal A; Wani S; Sharma P
    Gastrointest Endosc; 2008 Mar; 67(3):394-8. PubMed ID: 18045592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low Risk of High-Grade Dysplasia or Esophageal Adenocarcinoma Among Patients With Barrett's Esophagus Less Than 1 cm (Irregular Z Line) Within 5 Years of Index Endoscopy.
    Thota PN; Vennalaganti P; Vennelaganti S; Young P; Gaddam S; Gupta N; Lieberman D; Sampliner R; Falk GW; Mathur S; Kennedy K; Cash BD; Moawad F; Bansal A; Spaander MC; Bruno MJ; Vargo J; Sharma P
    Gastroenterology; 2017 Apr; 152(5):987-992. PubMed ID: 27988383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esophageal adenocarcinoma arising after antireflux surgery: a population-based analysis.
    Kauttu TM; Rantanen TK; Sihvo EI; Räsänen JV; Puolakkainen P; Salo JA
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1450-4; discussion 1454. PubMed ID: 21546258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.